BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2017
View Archived Issues
Crestovo initiates phase III trial of CP-101 to prevent C. difficile infection
Read More
KemPharm reveals new ADHD candidate
Read More
KIAA0125 found as an unfavorable prognostic marker in acute myeloid leukemia
Read More
New zebrafish Fanconi anemia-like model developed
Read More
FDA grants orphan drug designation for ABO-201 juvenile Batten disease gene therapy program
Read More
Alcyone Lifesciences and Pfizer enter feasibility study agreement
Read More
Gene-edited hematopoietic stem/progenitor cells created for SCID-X1
Read More
Paion completes phase III program for remimazolam for procedural sedation
Read More
Alkermes reports phase III data on ALKS-3831 in schizophrenia
Read More
Auspherix patents gold complexes for treating bacterial infections
Read More
Endpoints met in Lee's phase Ib/IIa study of adapalene/clindamycin gel for acne
Read More
Merck & Co. presents oxysterols receptor LXR-beta agonists
Read More
FORWARD II finds mirvetuximab soravtansine safe in combination therapies for ovarian cancer
Read More
Luc Therapeutics discloses NMDA receptor modulators
Read More
Research Triangle Institute divulges apelin receptor agonists
Read More
Janssen Pharmaceutica discovers BTK inhibitors
Read More
Cara Therapeutics reports phase IIb topline results on oral CR-845 for osteoarthritis pain
Read More
Heptares Therapeutics and PeptiDream enter inflammatory disease collaboration
Read More
Windtree reports topline phase IIb results for Aerosurf to treat RDS in premature infants
Read More
Sanpower Group completes Dendreon acquisition
Read More
FDA grants orphan drug designation to ganaxolone for CDKL5 disorder
Read More
FDA seeks to eliminate orphan drug designation request backlog
Read More
Acorda submits NDA for Inbrija to treat off episodes in Parkinson's disease
Read More
miR15a-5p identified as a biomarker of recurrence in colorectal carcinoma
Read More
Polatuzumab vedotin is eligible for access to EMA's PRIME program
Read More
Eiger Biopharmaceuticals selling Mydicar to Theragene Pharmaceuticals
Read More
FDA grants QIDP designation to Amphora for gonorrhea and bacterial vaginosis
Read More